--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
SPORTS
LIFE
PEOPLE
TRAVEL
WEEKLY REVIEW
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates
Hotel Service
China Calendar


Hot Links
China Development Gateway
Chinese Embassies

Manufacturers, Exporters, Wholesalers - Global trade starts here.

China's First SARS Treatment Drug Approved for Clinical Trial
China's State Food and Drug Administration has approved the clinical use on a trial basis of a drug potentially beneficial in the treatment of severe acute respiratory syndrome (SARS).

A source with the administration said Tuesday that the drug, named "Sivelestat Sodium", is a chemical injection which will increase the respiratory capacity of SARS patients, reducing reliance on respirators and thus greatly reducing the incidence of complications such as infection of the respiratory tract and acute damages to the lungs.

Declining to give any details about the drug developer, the administration, which received the application on May 7, has been conducting further tests on the potential effectiveness of the medicine, the source noted.

Earlier, the administration approved clinical trial-use for two SARS prevention drugs, and two reagents used in testing for the SARS virus have been authorized to enter batch production.

(Xinhua News Agency May 20, 2003)

Beijing Drugstores Back to Normal
China Develops New Medicine to Fight Drug Addiction
Print This Page | Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688